The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 7, 2003, Pages 678-680

  Fung, W L Alan ^a   Risch, Harvey ^b   McLaughlin, John ^c   Rosen, Barry ^d   Cole, David ^e   Vesprini, Danny ^a   Narod, Steven A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; GALACTOSE; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE;

ADULT; AGE; AGED; ALLELE; ARTICLE; CANADA; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ETHNIC GROUP; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CANADA; CASE-CONTROL STUDIES; FEMALE; GALACTOSE; GENOTYPE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; UTP-HEXOSE-1-PHOSPHATE URIDYLYLTRANSFERASE;

EID: 0041345935     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Shin, Y. S., Koch, H. G., Kohler, M., Hoffmann, G., Patsoura, A., and Podskarbi, T. Duarte-1 (Los Angeles) and Duarte-2 (Duarte) variants in Germany: two new mutations in the GALT gene which cause a GALT activity decrease by 40-50% of normal in red cells. J. Inherit. Metab., 21: 232-235, 1998.
2. Kaufman, F. R., Kogut, M. D., Donnell, G. N., Goebelsmann, U., March, C., and Koch, R. Hypergonadotropic hypogonadism in female patients with galaclosemia. N. Engl. J. Med., 304: 994-998, 1981.
3. Kaufman, F. R., Donnell, G. N., Roe, T. F., and Kogut, M. D. Gonadal function in patients with galactosemia. J. Inherit. Metab. Dis., 9: 140-146, 1986.
4. Waggoner, D. D., Buist, N. R. M., and Donnell, G. N. Long-term prognosis of galactosemia: results of a survey of 350 cases. J. Inherit. Metab. Dis., 13: 802-818, 1990.
5. Swartz, W. J., and Mattison, D. R. Galactose inhibition of ovulation in mice. Fertil. Steril., 49: 522-526, 1988.
6. Cramer, D. W. Lactase persistence and milk consumption as determinants of ovarian cancer risk. Am. J. Epidemiol., 130: 904-910, 1989.
7. Cramer, D. W., Harlow, B. L., Willett, W. C., Welch, W. R., Bell, D. A., Scully, R. E., Ng, W. G., and Knapp, R. C. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet, 2: 66-71, 1989.
8. Leslie, N. D., Immerman, E. B., Flach, J. E., Florez, M., Fridovich-Keil, J. L., and Elsas, L. J. The human galactose-1-phosphate uridyltransferase gene. Genomics, 14: 474-480, 1992.
9. Lin, H. C., Kirby, L. T., Ng, W. G., and Reichardt, J. K. V. On the molecular nature of the Duarte variant of galactose-1-phosphate uridyl transferase (GALT). Hum. Genet., 93: 167-169, 1994.
10. Elsas, L. J., Langley, S., Steele, E., Evinger, J., Fridovich-Keil, J. L., Brown, A., Singh, R., Fernhoff, P., Hjelm, L. N., and Dembure, P. P. Galactosemia: a strategy to identify new biochemical phenotypes and molecular genotypes. Am. J. Hum. Genet., 56: 630-639, 1995.
11. Cramer, D. W., Greenberg, E. R., Titus-Ernstoff, L., Liberman, R. F., Welch, W. R., Li, E., and Ng, W. G. A case-control study of galactose consumption and metabolism in relation to ovarian cancer. Cancer Epidemiol. Biomark. Prev., 9: 95-101, 2000.
12. Webb, P. M., Bain, C. J., Purdie, D. M., Harvey, P. W. J., and Green, A. Milk consumption, galactose metabolism and ovarian cancer (Australia). Cancer Causes Control, 9: 637-644, 1998.
13. Morland, S. J., Jiang, X., Hitchcock, A., Thomas, E. J., and Campbell, I. G. Mutation of galactose-1-phosphate uridyl transferase and its association with ovarian cancer and endometriosis. Int. J. Cancer, 77: 825-827, 1998.
14. Herrinton, L. J., Weiss, N. S., Beresford, S. A., Stanford, J. L., Wolfla, D. M., Feng, Z., and Scott, C. R. Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer. Am. J. Epidemiol., 141: 407-416, 1995.
15. Goodman, M. T., Wu, A. H., Tung, K. H., McDuffie, K., Cramer, D. W., Wilkens, L. R., Terada, K., Reichardt, J. K., and Ng, W. G. Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancer. Am. J. Epidemiol., 156: 693-701, 2002.
16. Cozen, W., Peters, R., Reichardt, J. K., Ng, W., Felix, J. C., Wan, P., and Pike, M. C. Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes Control, 13: 113-120, 2002.
17. Risch, H. A., McLaughlin, J. R., Cole, D. E., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D. J., Kuperstein, G., Abrahamson, J. L., Fan, I., Wong, B., and Narod, S. A. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am. J. Hum. Genet., 68: 700-710, 2001.